leonurine analogs

Leonurine analogs are synthetic derivatives of the natural alkaloid leonurine, which is primarily found in the plant *Leonurus japonicus* Houtt. These analogs were developed to enhance the potency and drug-like properties of the parent compound for potential use in cancer therapy. Research conducted at the Penn State University College of Medicine has identified novel analogs that are significantly more potent than leonurine in inhibiting the growth and survival of various solid tumor cells. The mechanism of action involves the suppression of the signal transducer and activator of transcription 3 (STAT3) signaling pathway. This inhibition is achieved by blocking the activation of upstream kinases, specifically Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2). The resulting down-regulation of STAT3-regulated gene products, such as survivin, Bcl-xL, Bcl-2, cyclin D1, and Mcl-1, leads to the induction of apoptosis and suppression of tumor cell proliferation in models of melanoma, breast, pancreatic, prostate, and colon cancer.

Other names

Leonurine derivatives